Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00800098 · ClinicalTrials.gov registry record · Early Phase 1

Effects of an Herbal Topical Cream on Osteoarthritis Symptoms, Biomarkers, and Disease Progression in the Knee

A Early Phase 1 study, sponsored by Stanford University.

Completed
Registry status
Early Phase 1
Development phase
22
Enrollment target

NCT00800098: Completed Early Phase 1 study, sponsored by Stanford University.

NCT00800098 is a Early Phase 1 study that has completed, run by Stanford University. The registered enrollment target is 22 participants. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00800098, a Early Phase 1 study, has completed, sponsored by Stanford University.

COMPLETED
Registry status
Early Phase 1
Development phase
22 participants
Enrollment target

Study Summary

Arthritis Relief Plus (ARP) Cream is a natural, herbal cream that has been shown to provide pain relief and decreased stiffness. Anecdotal reports suggest that pain may continue to be reduced months after cream use is stopped, indicating that there could be some disease-modifying effects of the cream. The purpose of this study is to test the claim that the ARP cream can provide long-term pain relief to osteoarthritis patients after only a short period of use. The study will also try to determine whether the pain relief is accompanied with any measurable indications that the progression of osteoarthritis has slowed or halted

Interventions

  • DRUG herbal topical cream

Trial Details

FieldValue
Enrollment Target 22 participants
Start Date 2008-12
Est. Completion 2010-02
Phase Early Phase 1

Sponsor

Stanford University

1,744 total trials

What the Registry Record Tells You About NCT00800098

The ClinicalTrials.gov registry entry for NCT00800098 describes a study currently listed as completed, categorized as Early Phase 1. The registered enrollment target is 22 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Stanford University, which has 1,744 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which herbal topical cream is the first listed.

NCT00800098 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT00800098 about?

NCT00800098 is a clinical study titled "Effects of an Herbal Topical Cream on Osteoarthritis Symptoms, Biomarkers, and Disease Progression in the Knee". Arthritis Relief Plus (ARP) Cream is a natural, herbal cream that has been shown to provide pain relief and decreased stiffness. Anecdotal reports suggest that pain may continue to be reduced months after cream use is stopped, indicating that there could be some disease-modifying effects of the crea...

What is the current status of trial NCT00800098?

This trial is currently completed. It is a Early Phase 1 study. The enrollment target is 22 participants. The study started on 2008-12. Estimated completion is 2010-02.

What interventions are being tested in trial NCT00800098?

The interventions under investigation include: herbal topical cream (DRUG).

Who is sponsoring clinical trial NCT00800098?

This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.